Ivy Brain Tumor Center

Ivy Brain Tumor Center The largest Phase 0 Clinical Trials Program for aggressive brain cancer.

In compliance with federal and state privacy laws, please do not include any private health information in any message you send us through this channel.

Communicating with someone who has   starts with patience and understanding. 💙 These quick tips can help make conversati...
01/17/2026

Communicating with someone who has starts with patience and understanding. 💙 These quick tips can help make conversations easier for everyone. Simple adjustments—like speaking slowly, acknowledging frustration, and allowing extra time—can make a big difference.

01/15/2026

The Ivy Brain Tumor Center in Phoenix, Arizona is home to the largest Phase 0 clinical trials program in the world. Visit our website to learn more about our commitment to innovative research and patient care and review our active clinical trials.

https://bar.rw/4jBma9c

Do you have a glioblastoma with MTAP deletion? You may be eligible for this Phase 0/1 clinical trial evaluating BMS-9865...
01/14/2026

Do you have a glioblastoma with MTAP deletion? You may be eligible for this Phase 0/1 clinical trial evaluating BMS-986504, a PRMT5 inhibitor. Learn more: https://bar.rw/3YXytmZ

Stay informed on the latest updates from the Ivy Brain Tumor Center. Each month, we share research updates, highlights a...
01/13/2026

Stay informed on the latest updates from the Ivy Brain Tumor Center. Each month, we share research updates, highlights and patient stories delivered to your inbox. Subscribe: ➡️ https://bar.rw/3NIeO7P

New year, refined habits. Forget overwhelming resolutions; embrace small, sustainable steps for lasting well-being. This...
01/09/2026

New year, refined habits. Forget overwhelming resolutions; embrace small, sustainable steps for lasting well-being. This includes acknowledging our full range of emotions, as patient Jeff Muse shares: "Let it rip! Anger, sadness, fear—whatever you experience. Your shock and unexpected pain are real, but so is laughter, cheering, and feeling so driven by purpose and grit that you just might be more thankful for life than ever. All in one day!” By integrating these varied experiences, our habits truly support our overall health.

The Ivy Center is discovering tomorrow's treatments today through vital brain tumor research. Support our mission. Donat...
01/08/2026

The Ivy Center is discovering tomorrow's treatments today through vital brain tumor research. Support our mission. Donate now ➡️ https://bar.rw/45JQQzh

The Gray Matters Foundation is hosting its monthly online support group this Wednesday. Join us to support brain tumor s...
01/07/2026

The Gray Matters Foundation is hosting its monthly online support group this Wednesday. Join us to support brain tumor survivors and their caregivers.

January 14, 2026
4:00PM - 6:00PM (MST)
Click here to register: https://bar.rw/3N9cN4u

In early December, the Ivy Brain Tumor Center published a manuscript in Science Translational Medicine authored by Nader...
01/02/2026

In early December, the Ivy Brain Tumor Center published a manuscript in Science Translational Medicine authored by Nader Sanai, MD; Shwetal Mehta, PhD; Artak Tovmasyan, PhD; An-Chi Tien, PhD; Igor Barani, MD; Charuta Furey, MD; and Zaman Mirzadeh, MD, PhD, in collaboration with other Ivy Center team members. The manuscript presents results from our early-phase clinical trial utilizing sonodynamic therapy (SDT) in recurrent high-grade glioma patients. SDT pairs 5-aminolevulinic acid (5-ALA), which is metabolized to protoporphyrin IX in glioma cells, with noninvasive, image-guided focused ultrasound to trigger tumor-selective oxidative injury.

Click here to read: https://bar.rw/45sotFB

Thank you for a 2025 filled with shared dedication and remarkable community support. Your trust in the Ivy Brain Tumor C...
01/01/2026

Thank you for a 2025 filled with shared dedication and remarkable community support. Your trust in the Ivy Brain Tumor Center inspires our progress every day. Wishing you a New Year of health, happiness, and renewed hope! ✨

Happy Holidays from the Ivy Brain Tumor Center! Our team, strengthened by our shared collaborative spirit, had an amazin...
12/25/2025

Happy Holidays from the Ivy Brain Tumor Center! Our team, strengthened by our shared collaborative spirit, had an amazing time celebrating together. Wishing everyone a joyful and heartwarming season!✨

Earlier this month, we were inspired by the Midwestern University community, including student leaders like Brooke, who ...
12/24/2025

Earlier this month, we were inspired by the Midwestern University community, including student leaders like Brooke, who organized a 5K event to raise awareness for brain cancer. We appreciated the opportunity to connect with participants and recognize the shared commitment to awareness and support.

The Ivy Center is conducting a Phase 1/2 study evaluating the anti-cancer activity of emavusertib (CA-4948) alone or in ...
12/23/2025

The Ivy Center is conducting a Phase 1/2 study evaluating the anti-cancer activity of emavusertib (CA-4948) alone or in combination with ibrutinib in adults with relapsed or refractory hematologic malignancies.
🌐: https://bar.rw/4jucg9z
Talk to an Ivy Navigator today: 602-406-8605

Address

2910 North Third Avenue
Phoenix, AZ
85013

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+16024066489

Alerts

Be the first to know and let us send you an email when Ivy Brain Tumor Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Ivy Brain Tumor Center:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Ivy Brain Tumor Center

The Ivy Brain Tumor Center was founded to provide new avenues of hope for patients and families struggling with aggressive brain tumors. Our philosophy is to deploy scientifically rigorous and technologically advanced clinical trials that rapidly evaluate new therapeutic regimens and are tailored to exploit and attack individual tumor biologies.